Skip to main content
EXOZ
NASDAQ Life Sciences

eXoZymes Prices $15M Unit Offering at Two Shares Plus One Five-Year Warrant, Pricing Still TBD

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.4
Mkt Cap
$40.838M
52W Low
$3.24
52W High
$18.4
52W Position info
36% above low
Off High info
76% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

EXOZ sits 36% above its 52-week low of $3.24.

Summary

Three days after the S-1 registered up to $37.3M, eXoZymes' November 9 free writing prospectus sizes its underwritten offering at $15 million of units — two shares plus one five-year warrant each — with pricing still TBD.


Key Events · Financing and Capital Events · EXOZ

  • Offering Sized at $15 Million

    The FWP sets the underwritten deal at $15 million of units, each unit two common shares plus one five-year warrant; pricing is still TBD.

  • Dilution Depends on Final Price

    Against 9,304,701 common shares outstanding before the offering, $15M at today's $4.40 implies roughly 3.4M shares (about 37% of the pre-deal count), before warrant exercise — the actual figure moves with the offering price.

  • Underwriter Warrants Add Overhang

    On top of the investor warrants, underwriter warrants equal 6% of shares sold in this offering.

  • Proceeds Earmarked Through 2028

    Net proceeds of $13.95M ($15.0M gross less a 7% fee) are planned as $10.0M in 2027 and $3.95M in 2028, with $4.2M for NCT commercialization and scale-up.


Analysis · EXOZ · Life Sciences

Hard numbers now attach to the offering first registered on the November 6 S-1: $15 million of units, each unit two common shares plus one five-year warrant, with pricing still to come. For a company that carried a going-concern warning in its August 10-Q, this is survival capital rather than growth capital — and it lands on a small share base. The cap table shows 9,304,701 common shares outstanding before the deal, so $15 million at today's $4.40 would be roughly 3.4 million shares (about 37% of the pre-deal count), before counting the warrants. Where the deal actually prices will determine the real dilution, and the filing does not state it. Underwriters also take warrants equal to 6% of shares sold, adding further overhang.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EXOZ was trading at $4.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $40.8M. The 52-week trading range was $3.24 to $18.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EXOZ - Latest Insights

EXOZ
Nov 06, 2026, 5:12 PM EST
Filing Type: S-1
Importance Score:
8
Price at Filing: $4.40
Real-time Price: $4.40 info
Change: $0 (0%) info
Market Cap: $40.838M info
EXOZ
Aug 13, 2026, 3:50 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $4.40 info
Change: -$1.60 (-27%) info
Market Cap: $40.838M info
EXOZ
Jul 01, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $4.40 info
Change: -$4.10 (-48%) info
Market Cap: $40.838M info
EXOZ
Jul 01, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.50
Real-time Price: $4.40 info
Change: -$4.10 (-48%) info
Market Cap: $40.838M info
EXOZ
Jun 30, 2026, 4:15 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $8.43
Real-time Price: $4.40 info
Change: -$4.03 (-48%) info
Market Cap: $40.838M info